Electrographic Flow (EGF)™ mapping with Ablamap® is a novel technique to create full temporospatial visualizations of organized action potential flow within the chaotic conduction of atrial fibrillation. Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation.

Electrographic Flow™ mapping and ablation

previous arrow
next arrow
Slider

Ablamap® reveals action potential flow

previous arrow
next arrow
Slider

Electrographic Flow™ improves our understanding of Atrial Fibrillation

Phenomena revealed by Electrographic Flow mapping are related to the initiation and maintenance of AF.

previous arrow
next arrow
Slider

Ablamap® is CE Marked and commercially available in the EU.

Ablamap® is not commercially available in the United States and limited to research use.